Readout Health Biosense device to be tested in JDRF-funded clinical trial in people with Type 1 Diabetes using SGLT inhibitors at Washington University ...Middle East

$360,000 grant to review safety and accuracy of Biosense® device aimed at DKA risk mitigation in patients using SGLTi drug class. ST. LOUIS, July 12, 2022 /PRNewswire/ -- Readout Health, a medical digital health startup, announces a sponsored research agreement with Washington University...

Hence then, the article about readout health biosense device to be tested in jdrf funded clinical trial in people with type 1 diabetes using sglt inhibitors at washington university was published today ( Tuesday 12/07/2022 - 04:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Readout Health Biosense device to be tested in JDRF-funded clinical trial in people with Type 1 Diabetes using SGLT inhibitors at Washington University )

Also on site :

• Peter Alexander is leaving NBC after years of being passed over for top anchor jobs: source
• This Can't Miss Scenic Spot Just Under an Hour from Vegas Will Have You Feeling Like You're in Another World
• This Spring, Divest From Clutter to Reclaim Personal Productivity Like a Boss .. PYMNTS.com